BCD-054
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BCD-054, covering 2016-12-23 to 2021-09-08. Get the full timeline:
Most recent: Clinical Trial Update: Comparative Clinical Trial to Evaluate Efficacy, Safety and Tolerance of BCD-054 and Avonex® for Treatment of Patients With Remitting-relapsing Multiple Sclerosis [Phase 2, Phase 3]